- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Hyperbaric oxygen therapy improves symptoms and QOL in kids with persistent post-concussion syndrome
![Hyperbaric oxygen therapy improves symptoms and QOL in kids with persistent post-concussion syndrome Hyperbaric oxygen therapy improves symptoms and QOL in kids with persistent post-concussion syndrome](https://medicaldialogues.in/h-upload/2021/04/28/750x450_151708-oxygen-cylinder.webp)
A new study conducted by Amir Hadanny and team shows that even years after injury, hyperbaric oxygen therapy (HBOT) improves quality of life, symptoms, cognitive performance, and behavioral function in young persistent post-concussion syndrome (PPCS) patients.
The findings of this study were published in Nature Scientific Reports.
Following traumatic brain injury (TBI), persistent post-concussion syndrome (PPCS) is a common and serious morbidity in children, and there is currently no research supporting effective PPCS therapies. Hyperbaric oxygen treatment has been demonstrated to be effective for adult PPCS patients in recent research. This investigation was carried out to assess the effects of HBOT on a juvenile population suffering from PPCS after TBI, with persistent symptoms for at least six months following injury.
The effectiveness of hyperbaric oxygen therapy on children (ages 8 to 15) with PPCS from mild-moderate TBI incidents six months to ten years earlier was examined in this randomized, sham-control, double-blind experiment.
The key findings of this study were:
1. Twenty-five youngsters were randomly assigned to either HBOT (n = 15) or sham (n = 10) treatments for 60 daily sessions.
2. Following HBOT, there was a significant improvement in cognitive function, including the general cognitive score (d = 0.598, p = 0.01), memory (d = 0.480, p = 0.02), executive function (d = 0.739, p = 0.003), PPCS symptoms including emotional score (p = 0.04, d = - 0.676), behavioral symptoms including hyperactivity (d = 0.244, p = 0.03), global executive composite score (d = 0.5).
3. Significant improvements in brain MRI microstructural alterations in the insula, lingual, supramarginal, inferior frontal, and fusiform gyri corresponded with clinical results.
In conclusion, according to the study, HBOT helps children with PPCS perform better cognitively and behaviorally, as well as their PPCS and quality of life, even years after the initial damage. To improve the process and identify the kids who would benefit most from it, more information is required.
Reference:
Hadanny, A., Catalogna, M., Yaniv, S., Stolar, O., Rothstein, L., Shabi, A., Suzin, G., Sasson, E., Lang, E., Finci, S., Harpaz, R. T., Bechor, Y., & Efrati, S. (2022). Hyperbaric oxygen therapy in children with post-concussion syndrome improves cognitive and behavioral function: a randomized controlled trial. In Scientific Reports (Vol. 12, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1038/s41598-022-19395-y
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751